Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Gregory Renza is an analyst at RBC Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/13/2025 | EXEL | Buy Now | Exelixis | $36.36 | 10.01% | Gregory Renza49% | $38 → $40 | Maintains | Outperform | Get Alert |
| 02/26/2025 | JAZZ | Buy Now | Jazz Pharmaceuticals | $139.51 | 27.59% | Gregory Renza49% | $179 → $178 | Maintains | Outperform | Get Alert |
| 01/29/2025 | NRIX | Buy Now | Nurix Therapeutics | $13.66 | 97.66% | Gregory Renza49% | $26 → $27 | Maintains | Outperform | Get Alert |
| 01/24/2025 | AMGN | Buy Now | Amgen | $319.93 | 1.27% | Gregory Renza49% | $324 → $324 | Reiterates | Outperform → Outperform | Get Alert |
| 01/15/2025 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 230.27% | Gregory Renza49% | $61 → $61 | Reiterates | Outperform → Outperform | Get Alert |
| 01/14/2025 | CATX | Buy Now | Perspective Therapeutics | $2.47 | 547.77% | Gregory Renza49% | $16 → $16 | Reiterates | Outperform → Outperform | Get Alert |
| 01/14/2025 | PCRX | Buy Now | Pacira BioSciences | $23.67 | -23.95% | Gregory Renza49% | $18 → $18 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 01/09/2025 | JSPR | Buy Now | Jasper Therapeutics | $5.22 | 819.54% | Gregory Renza49% | $68 → $48 | Maintains | Outperform | Get Alert |
| 01/07/2025 | VSTM | Buy Now | Verastem | $6.50 | 146.15% | Gregory Renza49% | $13 → $16 | Maintains | Outperform | Get Alert |
| 01/07/2025 | NUVB | Buy Now | Nuvation Bio | $1.91 | 423.01% | Gregory Renza49% | $6 → $10 | Reiterates | Outperform → Outperform | Get Alert |
| 12/23/2024 | JSPR | Buy Now | Jasper Therapeutics | $5.22 | 1202.68% | Gregory Renza49% | $68 → $68 | Reiterates | Outperform → Outperform | Get Alert |
| 12/19/2024 | CRMD | Buy Now | Cormedix | $10.43 | 15.05% | Gregory Renza49% | $11 → $12 | Maintains | Outperform | Get Alert |
| 12/19/2024 | MNKD | Buy Now | MannKind | $5.21 | 91.94% | Gregory Renza49% | $7 → $10 | Upgrade | Sector Perform → Outperform | Get Alert |
| 12/17/2024 | VRDN | Buy Now | Viridian Therapeutics | $15.14 | 210.44% | Gregory Renza49% | $44 → $47 | Maintains | Outperform | Get Alert |
| 12/13/2024 | CDTX | Buy Now | Cidara Therapeutics | $22.40 | 51.79% | Gregory Renza49% | → $34 | Initiates | → Outperform | Get Alert |
| 12/12/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $139.51 | 28.31% | Gregory Renza49% | $179 → $179 | Reiterates | Outperform → Outperform | Get Alert |
| 12/11/2024 | SPRB | Buy Now | Spruce Biosciences | $0.34 | 338.98% | Gregory Renza49% | $2 → $1.5 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 12/10/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 82.69% | Gregory Renza49% | $55 → $57 | Maintains | Outperform | Get Alert |
| 12/10/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $139.51 | 28.31% | Gregory Renza49% | $179 → $179 | Reiterates | Outperform → Outperform | Get Alert |
| 12/06/2024 | CGON | Buy Now | CG Oncology | $27.48 | 140.17% | Gregory Renza49% | $66 → $66 | Reiterates | Outperform → Outperform | Get Alert |
| 12/05/2024 | VRDN | Buy Now | Viridian Therapeutics | $15.14 | 190.62% | Gregory Renza49% | $44 → $44 | Reiterates | Outperform → Outperform | Get Alert |
| 11/27/2024 | AMGN | Buy Now | Amgen | $319.93 | 3.15% | Gregory Renza49% | $360 → $330 | Maintains | Outperform | Get Alert |
| 11/25/2024 | CATX | Buy Now | Perspective Therapeutics | $2.47 | 547.77% | Gregory Renza49% | $25 → $16 | Maintains | Outperform | Get Alert |
| 11/15/2024 | INO | Buy Now | Inovio Pharmaceuticals | $2.12 | 183.03% | Gregory Renza49% | $7 → $6 | Maintains | Sector Perform | Get Alert |
| 11/14/2024 | VIRX | Buy Now | Viracta Therapeutics | $0.02 | 8063.27% | Gregory Renza49% | $4 → $2 | Maintains | Outperform | Get Alert |
| 11/14/2024 | FULC | Buy Now | Fulcrum Therapeutics | $3.02 | 32.45% | Gregory Renza49% | $4 → $4 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 11/12/2024 | SPRB | Buy Now | Spruce Biosciences | $0.34 | 485.31% | Gregory Renza49% | $2 → $2 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 11/07/2024 | PCRX | Buy Now | Pacira BioSciences | $23.67 | -32.4% | Gregory Renza49% | $15 → $16 | Maintains | Sector Perform | Get Alert |
| 11/07/2024 | NUVB | Buy Now | Nuvation Bio | $1.91 | 213.81% | Gregory Renza49% | $5 → $6 | Maintains | Outperform | Get Alert |
| 11/05/2024 | VRCA | Buy Now | Verrica Pharmaceuticals | $0.65 | 207.69% | Gregory Renza49% | $11 → $2 | Downgrade | Outperform → Sector Perform | Get Alert |
| 11/01/2024 | BCYC | Buy Now | Bicycle Therapeutics | $9.57 | 265.73% | Gregory Renza49% | $35 → $35 | Reiterates | Outperform → Outperform | Get Alert |
| 11/01/2024 | AGIO | Buy Now | Alnylam Pharmaceuticals | $31.20 | 76.28% | Gregory Renza49% | $55 → $55 | Reiterates | Outperform → Outperform | Get Alert |
| 10/30/2024 | EXEL | Buy Now | Exelixis | $36.36 | -6.49% | Gregory Renza49% | $34 → $34 | Reiterates | Outperform → Outperform | Get Alert |
| 10/23/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $139.51 | 28.31% | Gregory Renza49% | $175 → $179 | Maintains | Outperform | Get Alert |
| 10/18/2024 | VSTM | Buy Now | Verastem | $6.50 | 100% | Gregory Renza49% | $13 → $13 | Reiterates | Outperform → Outperform | Get Alert |
| 10/16/2024 | EXEL | Buy Now | Exelixis | $36.36 | -6.49% | Gregory Renza49% | $30 → $34 | Maintains | Outperform | Get Alert |
| 10/14/2024 | NRIX | Buy Now | Nurix Therapeutics | $13.66 | 90.34% | Gregory Renza49% | $27 → $26 | Maintains | Outperform | Get Alert |
| 10/04/2024 | VRCA | Buy Now | Verrica Pharmaceuticals | $0.65 | 1592.31% | Gregory Renza49% | $13 → $11 | Maintains | Outperform | Get Alert |
| 10/04/2024 | PCRX | Buy Now | Pacira BioSciences | $23.67 | -36.63% | Gregory Renza49% | $14 → $15 | Maintains | Sector Perform | Get Alert |
| 10/04/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $139.51 | 25.44% | Gregory Renza49% | $174 → $175 | Maintains | Outperform | Get Alert |
| 10/04/2024 | INO | Buy Now | Inovio Pharmaceuticals | $2.12 | 230.2% | Gregory Renza49% | $8 → $7 | Maintains | Sector Perform | Get Alert |
| 10/04/2024 | EXEL | Buy Now | Exelixis | $36.36 | -17.49% | Gregory Renza49% | $27 → $30 | Maintains | Outperform | Get Alert |
| 09/26/2024 | XNCR | Buy Now | Xencor | $12.52 | 171.57% | Gregory Renza49% | $31 → $34 | Maintains | Outperform | Get Alert |
| 09/26/2024 | EXEL | Buy Now | Exelixis | $36.36 | -25.74% | Gregory Renza49% | $27 → $27 | Reiterates | Outperform → Outperform | Get Alert |
| 09/26/2024 | AMGN | Buy Now | Amgen | $319.93 | 13.15% | Gregory Renza49% | $362 → $362 | Reiterates | Outperform → Outperform | Get Alert |
| 09/24/2024 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 230.27% | Gregory Renza49% | $61 → $61 | Reiterates | Outperform → Outperform | Get Alert |
| 09/23/2024 | CGON | Buy Now | CG Oncology | $27.48 | 140.17% | Gregory Renza49% | → $66 | Initiates | → Outperform | Get Alert |
| 09/19/2024 | VRDN | Buy Now | Viridian Therapeutics | $15.14 | 190.62% | Gregory Renza49% | $44 → $44 | Reiterates | Outperform → Outperform | Get Alert |
| 09/19/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 76.28% | Gregory Renza49% | $55 → $55 | Reiterates | Outperform → Outperform | Get Alert |
| 09/13/2024 | VRDN | Buy Now | Viridian Therapeutics | $15.14 | 190.62% | Gregory Renza49% | $35 → $44 | Maintains | Outperform | Get Alert |
| 09/13/2024 | FULC | Buy Now | Fulcrum Therapeutics | $3.02 | 32.45% | Gregory Renza49% | $15 → $4 | Downgrade | Outperform → Sector Perform | Get Alert |
| 09/06/2024 | BCYC | Buy Now | Bicycle Therapeutics | $9.57 | 265.73% | Gregory Renza49% | → $35 | Initiates | → Outperform | Get Alert |
| 08/28/2024 | VRDN | Buy Now | Viridian Therapeutics | $15.14 | 131.18% | Gregory Renza49% | $35 → $35 | Reiterates | Outperform → Outperform | Get Alert |
| 08/16/2024 | CATX | Buy Now | Perspective Therapeutics | $2.47 | 993.12% | Gregory Renza49% | $29 → $27 | Maintains | Outperform | Get Alert |
| 08/15/2024 | VRCA | Buy Now | Verrica Pharmaceuticals | $0.65 | 1900% | Gregory Renza49% | $14 → $13 | Maintains | Outperform | Get Alert |
| 08/15/2024 | VIRX | Buy Now | Viracta Therapeutics | $0.02 | 16226.53% | Gregory Renza49% | $6 → $4 | Maintains | Outperform | Get Alert |
| 08/15/2024 | CRMD | Buy Now | Cormedix | $10.43 | -13.71% | Gregory Renza49% | $9 → $9 | Reiterates | Outperform → Outperform | Get Alert |
| 08/14/2024 | ATYR | Buy Now | aTyr Pharma | $3.92 | 308.16% | Gregory Renza49% | $16 → $16 | Reiterates | Outperform → Outperform | Get Alert |
| 08/14/2024 | JSPR | Buy Now | Jasper Therapeutics | $5.22 | 1202.68% | Gregory Renza49% | $70 → $68 | Maintains | Outperform | Get Alert |
| 08/13/2024 | SPRB | Buy Now | Spruce Biosciences | $0.34 | 485.31% | Gregory Renza49% | $2 → $2 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 08/12/2024 | PCRX | Buy Now | Pacira BioSciences | $23.67 | -40.85% | Gregory Renza49% | $37 → $14 | Downgrade | Outperform → Sector Perform | Get Alert |
| 08/09/2024 | VSTM | Buy Now | Verastem | $6.50 | 100% | Gregory Renza49% | $16 → $13 | Maintains | Outperform | Get Alert |
| 08/09/2024 | INO | Buy Now | Inovio Pharmaceuticals | $2.12 | 277.38% | Gregory Renza49% | $11 → $8 | Maintains | Sector Perform | Get Alert |
| 08/07/2024 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 230.27% | Gregory Renza49% | $61 → $61 | Reiterates | Outperform → Outperform | Get Alert |
| 08/07/2024 | EXEL | Buy Now | Exelixis | $36.36 | -25.74% | Gregory Renza49% | $27 → $27 | Reiterates | Outperform → Outperform | Get Alert |
| 08/07/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 44.44% | Gregory Renza49% | $29 → $26 | Maintains | Outperform | Get Alert |
| 08/07/2024 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 337.16% | Gregory Renza49% | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 08/07/2024 | AMGN | Buy Now | Amgen | $319.93 | 13.15% | Gregory Renza49% | $332 → $362 | Maintains | Outperform | Get Alert |
| 08/06/2024 | XNCR | Buy Now | Xencor | $12.52 | 147.6% | Gregory Renza49% | $31 → $31 | Reiterates | Outperform → Outperform | Get Alert |
| 08/06/2024 | NUVB | Buy Now | Nuvation Bio | $1.91 | 161.51% | Gregory Renza49% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert |
| 08/02/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 76.28% | Gregory Renza49% | $53 → $55 | Maintains | Outperform | Get Alert |
| 08/01/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $139.51 | 24.72% | Gregory Renza49% | $175 → $174 | Maintains | Outperform | Get Alert |
| 07/31/2024 | PCRX | Buy Now | Pacira BioSciences | $23.67 | 56.32% | Gregory Renza49% | $42 → $37 | Maintains | Outperform | Get Alert |
| 07/26/2024 | MORF | Buy Now | Morphic Holding | — | — | Gregory Renza49% | $57 → $57 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 07/12/2024 | NRIX | Buy Now | Nurix Therapeutics | $13.66 | 97.66% | Gregory Renza49% | $26 → $27 | Maintains | Outperform | Get Alert |
| 07/11/2024 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 230.27% | Gregory Renza49% | $53 → $61 | Maintains | Outperform | Get Alert |
| 07/09/2024 | MORF | Buy Now | Morphic Holding | — | — | Gregory Renza49% | $70 → $57 | Downgrade | Outperform → Sector Perform | Get Alert |
| 06/27/2024 | NRIX | Buy Now | Nurix Therapeutics | $13.66 | 90.34% | Gregory Renza49% | $23 → $26 | Maintains | Outperform | Get Alert |
| 06/25/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 61.11% | Gregory Renza49% | $29 → $29 | Reiterates | Outperform → Outperform | Get Alert |
| 06/14/2024 | XNCR | Buy Now | Xencor | $12.52 | 147.6% | Gregory Renza49% | $32 → $31 | Maintains | Outperform | Get Alert |
| 06/14/2024 | CATX | Buy Now | Perspective Therapeutics | $2.47 | 21.46% | Gregory Renza49% | $30 → $30 | Reiterates | Outperform → Outperform | Get Alert |
| 06/14/2024 | AMGN | Buy Now | Amgen | $319.93 | 3.77% | Gregory Renza49% | $328 → $332 | Maintains | Outperform | Get Alert |
| 06/04/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 69.87% | Gregory Renza49% | $44 → $53 | Maintains | Outperform | Get Alert |
| 05/28/2024 | VSTM | Buy Now | Verastem | $6.50 | 146.15% | Gregory Renza49% | $32 → $16 | Maintains | Outperform | Get Alert |
| 05/14/2024 | CATX | Buy Now | Perspective Therapeutics | $2.47 | 21.46% | Gregory Renza49% | → $30 | Initiates | → Outperform | Get Alert |
| 05/03/2024 | AMGN | Buy Now | Amgen | $319.93 | 2.52% | Gregory Renza49% | $332 → $328 | Maintains | Outperform | Get Alert |
| 04/11/2024 | NRIX | Buy Now | Nurix Therapeutics | $13.66 | 68.37% | Gregory Renza49% | $22 → $23 | Maintains | Outperform | Get Alert |
| 04/11/2024 | ALPN | Buy Now | Alpine Immune Sciences | — | — | Gregory Renza49% | $41 → $65 | Downgrade | Outperform → Sector Perform | Get Alert |
| 04/03/2024 | AMGN | Buy Now | Amgen | $319.93 | 2.84% | Gregory Renza49% | $329 → $329 | Reiterates | Outperform → Outperform | Get Alert |
| 03/28/2024 | JSPR | Buy Now | Jasper Therapeutics | $5.22 | 1241% | Gregory Renza49% | → $70 | Initiates | → Outperform | Get Alert |
| 03/21/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Gregory Renza49% | $21 → $21 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 03/20/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Gregory Renza49% | $16 → $21 | Downgrade | Outperform → Sector Perform | Get Alert |
| 03/15/2024 | VSTM | Buy Now | Verastem | $6.50 | 392.31% | Gregory Renza49% | $32 → $32 | Reiterates | Outperform → Outperform | Get Alert |
| 03/15/2024 | LIFE | Buy Now | aTyr Pharma | — | — | Gregory Renza49% | $19 → $16 | Maintains | Outperform | Get Alert |
| 03/14/2024 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 337.16% | Gregory Renza49% | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 03/14/2024 | SPRB | Buy Now | Spruce Biosciences | $0.34 | 485.31% | Gregory Renza49% | $9 → $2 | Downgrade | Outperform → Sector Perform | Get Alert |
| 03/13/2024 | FULC | Buy Now | Fulcrum Therapeutics | $3.02 | 363.58% | Gregory Renza49% | → $14 | Initiates | → Outperform | Get Alert |
| 03/13/2024 | CRMD | Buy Now | Cormedix | $10.43 | -13.71% | Gregory Renza49% | $10 → $9 | Maintains | Outperform | Get Alert |
| 03/12/2024 | ALPN | Buy Now | Alpine Immune Sciences | — | — | Gregory Renza49% | $29 → $41 | Maintains | Outperform | Get Alert |
| 03/12/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 66.67% | Gregory Renza49% | $35 → $30 | Maintains | Outperform | Get Alert |
| 03/07/2024 | INO | Buy Now | Inovio Pharmaceuticals | $2.12 | 418.89% | Gregory Renza49% | → $11 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 03/05/2024 | SPRB | Buy Now | Spruce Biosciences | $0.34 | 2533.89% | Gregory Renza49% | $9 → $9 | Reiterates | Outperform → Outperform | Get Alert |
| 03/04/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Gregory Renza49% | $12 → $16 | Maintains | Outperform | Get Alert |
| 03/01/2024 | PCRX | Buy Now | Pacira BioSciences | $23.67 | 90.11% | Gregory Renza49% | $53 → $45 | Maintains | Outperform | Get Alert |
| 02/29/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $139.51 | 39.77% | Gregory Renza49% | $195 → $195 | Reiterates | Outperform → Outperform | Get Alert |
| 02/28/2024 | XNCR | Buy Now | Xencor | $12.52 | 155.59% | Gregory Renza49% | $32 → $32 | Reiterates | Outperform → Outperform | Get Alert |
| 02/28/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 94.44% | Gregory Renza49% | $36 → $35 | Maintains | Outperform | Get Alert |
| 02/26/2024 | SPRB | Buy Now | Spruce Biosciences | $0.34 | 2533.89% | Gregory Renza49% | $8 → $9 | Maintains | Outperform | Get Alert |
| 02/26/2024 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 337.16% | Gregory Renza49% | $6 → $8 | Maintains | Outperform | Get Alert |
| 02/21/2024 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 186.95% | Gregory Renza49% | $43 → $53 | Maintains | Outperform | Get Alert |
| 02/16/2024 | NRIX | Buy Now | Nurix Therapeutics | $13.66 | 61.05% | Gregory Renza49% | $24 → $22 | Maintains | Outperform | Get Alert |
| 02/16/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $31.20 | 34.62% | Gregory Renza49% | $43 → $42 | Maintains | Outperform | Get Alert |
| 02/07/2024 | EXEL | Buy Now | Exelixis | $36.36 | -22.99% | Gregory Renza49% | $26 → $28 | Maintains | Outperform | Get Alert |
| 02/07/2024 | AMGN | Buy Now | Amgen | $319.93 | 2.84% | Gregory Renza49% | $303 → $329 | Maintains | Outperform | Get Alert |
| 01/10/2024 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 132.81% | Gregory Renza49% | $36 → $43 | Maintains | Outperform | Get Alert |
| 12/20/2023 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Gregory Renza49% | → $12 | Initiates | → Outperform | Get Alert |
| 12/14/2023 | VRDN | Buy Now | Viridian Therapeutics | $15.14 | 131.18% | Gregory Renza49% | $35 → $35 | Reiterates | Outperform → Outperform | Get Alert |
| 12/13/2023 | EXEL | Buy Now | Exelixis | $36.36 | -28.49% | Gregory Renza49% | $26 → $26 | Reiterates | Outperform → Outperform | Get Alert |
| 12/12/2023 | AMGN | Buy Now | Amgen | $319.93 | -6.23% | Gregory Renza49% | $256 → $300 | Upgrade | Sector Perform → Outperform | Get Alert |
| 12/06/2023 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 94.91% | Gregory Renza49% | $36 → $36 | Reiterates | Outperform → Outperform | Get Alert |
| 11/15/2023 | CRMD | Buy Now | Cormedix | $10.43 | -4.12% | Gregory Renza49% | $6 → $10 | Maintains | Outperform | Get Alert |
| 11/14/2023 | VRDN | Buy Now | Viridian Therapeutics | $15.14 | 131.18% | Gregory Renza49% | → $35 | Reiterates | Outperform → Outperform | Get Alert |
| 11/10/2023 | VIRX | Buy Now | Viracta Therapeutics | $0.02 | 24389.8% | Gregory Renza49% | $7 → $6 | Maintains | Outperform | Get Alert |
| 11/10/2023 | APTO | Buy Now | Aptose Biosciences | $3.78 | 376.19% | Gregory Renza49% | $690 → $540 | Maintains | Outperform | Get Alert |
| 11/09/2023 | JAZZ | Buy Now | Jazz Pharmaceuticals | $139.51 | 36.91% | Gregory Renza49% | $200 → $191 | Maintains | Outperform | Get Alert |
| 11/08/2023 | XNCR | Buy Now | Xencor | $12.52 | 155.59% | Gregory Renza49% | $36 → $32 | Maintains | Outperform | Get Alert |
| 11/08/2023 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 227.87% | Gregory Renza49% | $7 → $6 | Maintains | Outperform | Get Alert |
| 11/03/2023 | PCRX | Buy Now | Pacira BioSciences | $23.67 | 145.04% | Gregory Renza49% | $67 → $58 | Maintains | Outperform | Get Alert |
| 11/03/2023 | ALPN | Buy Now | Alpine Immune Sciences | — | — | Gregory Renza49% | $19 → $22 | Maintains | Outperform | Get Alert |
| 11/03/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 83.33% | Gregory Renza49% | $32 → $33 | Maintains | Outperform | Get Alert |
| 11/02/2023 | NRIX | Buy Now | Nurix Therapeutics | $13.66 | 75.7% | Gregory Renza49% | $29 → $24 | Maintains | Outperform | Get Alert |
| 11/02/2023 | AMGN | Buy Now | Amgen | $319.93 | -19.98% | Gregory Renza49% | $253 → $256 | Maintains | Sector Perform | Get Alert |
| 11/01/2023 | AMGN | Buy Now | Amgen | $319.93 | -19.98% | Gregory Renza49% | $253 → $256 | Maintains | Sector Perform | Get Alert |
| 10/31/2023 | VRDN | Buy Now | Viridian Therapeutics | $15.14 | 131.18% | Gregory Renza49% | $44 → $35 | Maintains | Outperform | Get Alert |
| 10/24/2023 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 94.91% | Gregory Renza49% | $32 → $36 | Maintains | Outperform | Get Alert |
| 10/13/2023 | NRIX | Buy Now | Nurix Therapeutics | $13.66 | 112.3% | Gregory Renza49% | $30 → $29 | Maintains | Outperform | Get Alert |
| 10/11/2023 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 73.25% | Gregory Renza49% | → $32 | Reiterates | Outperform → Outperform | Get Alert |
| 10/05/2023 | VIRX | Buy Now | Viracta Therapeutics | $0.02 | 28471.43% | Gregory Renza49% | → $7 | Reiterates | Outperform → Outperform | Get Alert |
| 10/05/2023 | ALPN | Buy Now | Alpine Immune Sciences | — | — | Gregory Renza49% | → $19 | Initiates | → Outperform | Get Alert |
| 10/03/2023 | PCRX | Buy Now | Pacira BioSciences | $23.67 | 187.28% | Gregory Renza49% | → $68 | Reiterates | Outperform → Outperform | Get Alert |
| 09/13/2023 | SPRB | Buy Now | Spruce Biosciences | $0.34 | 2241.24% | Gregory Renza49% | → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 09/12/2023 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 337.16% | Gregory Renza49% | $9 → $8 | Maintains | Outperform | Get Alert |
| 08/15/2023 | VIRX | Buy Now | Viracta Therapeutics | $0.02 | 28471.43% | Gregory Renza49% | → $7 | Reiterates | Outperform → Outperform | Get Alert |
| 08/15/2023 | SPRB | Buy Now | Spruce Biosciences | $0.34 | 2241.24% | Gregory Renza49% | → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 08/11/2023 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 73.25% | Gregory Renza49% | $30 → $32 | Maintains | Outperform | Get Alert |
| 08/11/2023 | APTO | Buy Now | Aptose Biosciences | $3.78 | 508.47% | Gregory Renza49% | $1200 → $690 | Maintains | Outperform | Get Alert |
| 08/10/2023 | JAZZ | Buy Now | Jazz Pharmaceuticals | $139.51 | 44.08% | Gregory Renza49% | $203 → $201 | Maintains | Outperform | Get Alert |
| 08/10/2023 | CRMD | Buy Now | Cormedix | $10.43 | -42.47% | Gregory Renza49% | → $6 | Initiates | → Outperform | Get Alert |
| 08/09/2023 | VRDN | Buy Now | Viridian Therapeutics | $15.14 | 190.62% | Gregory Renza49% | → $44 | Reiterates | Outperform → Outperform | Get Alert |
| 08/09/2023 | VSTM | Buy Now | Verastem | $6.50 | 392.31% | Gregory Renza49% | $34 → $32 | Maintains | Outperform | Get Alert |
| 08/09/2023 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 391.8% | Gregory Renza49% | $10 → $9 | Maintains | Outperform | Get Alert |
| 08/04/2023 | AMGN | Buy Now | Amgen | $319.93 | -20.92% | Gregory Renza49% | $250 → $253 | Maintains | Sector Perform | Get Alert |
| 08/03/2023 | PCRX | Buy Now | Pacira BioSciences | $23.67 | 187.28% | Gregory Renza49% | $70 → $68 | Maintains | Outperform | Get Alert |
| 07/25/2023 | VRCA | Buy Now | Verrica Pharmaceuticals | $0.65 | 2053.85% | Gregory Renza49% | $11 → $14 | Maintains | Outperform | Get Alert |
| 07/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 83.33% | Gregory Renza49% | $28 → $33 | Maintains | Outperform | Get Alert |
| 07/11/2023 | VRDN | Buy Now | Viridian Therapeutics | $15.14 | 190.62% | Gregory Renza49% | → $44 | Reiterates | Outperform → Outperform | Get Alert |
| 07/03/2023 | VSTM | Buy Now | Verastem | $6.50 | 423.08% | Gregory Renza49% | $36 → $34 | Maintains | Outperform | Get Alert |
| 06/27/2023 | AVTX | Buy Now | Avalo Therapeutics | $7.38 | -89.84% | Gregory Renza49% | $2160 → $180 | Downgrade | Outperform → Sector Perform | Get Alert |
| 06/07/2023 | APTO | Buy Now | Aptose Biosciences | $3.78 | 958.2% | Gregory Renza49% | $2250 → $1200 | Maintains | Outperform | Get Alert |
| 05/30/2023 | VRDN | Buy Now | Viridian Therapeutics | $15.14 | 190.62% | Gregory Renza49% | → $44 | Initiates | → Outperform | Get Alert |
| 05/16/2023 | SPRB | Buy Now | Spruce Biosciences | $0.34 | 2241.24% | Gregory Renza49% | → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 05/15/2023 | BLU | Buy Now | BELLUS Health | — | — | Gregory Renza49% | → $14.75 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 05/11/2023 | JAZZ | Buy Now | Jazz Pharmaceuticals | $139.51 | 44.79% | Gregory Renza49% | $207 → $202 | Maintains | Outperform | Get Alert |
| 05/11/2023 | INO | Buy Now | Inovio Pharmaceuticals | $2.12 | -5.66% | Gregory Renza49% | → $24 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 05/10/2023 | LIFE | Buy Now | aTyr Pharma | — | — | Gregory Renza49% | → $19 | Reiterates | → Outperform | Get Alert |
| 05/10/2023 | RXDX | Buy Now | Prometheus Biosciences | — | — | Gregory Renza49% | → $200 | Maintains | Sector Perform | Get Alert |
| 05/10/2023 | AVTX | Buy Now | Avalo Therapeutics | $7.38 | 21.95% | Gregory Renza49% | $4080 → $2160 | Maintains | Outperform | Get Alert |
| 05/10/2023 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 446.45% | Gregory Renza49% | $12 → $10 | Maintains | Outperform | Get Alert |
| 05/09/2023 | VIRX | Buy Now | Viracta Therapeutics | $0.02 | 28471.43% | Gregory Renza49% | $8 → $7 | Maintains | Outperform | Get Alert |
| 05/09/2023 | XNCR | Buy Now | Xencor | $12.52 | 187.54% | Gregory Renza49% | → $36 | Reiterates | → Outperform | Get Alert |
| 05/09/2023 | APTO | Buy Now | Aptose Biosciences | $3.78 | 32.28% | Gregory Renza49% | → $2250 | Reiterates | → Outperform | Get Alert |
| 05/09/2023 | AMGN | Buy Now | Amgen | $319.93 | -20.61% | Gregory Renza49% | → $254 | Reiterates | → Sector Perform | Get Alert |
| 05/09/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 50% | Gregory Renza49% | → $27 | Reiterates | → Outperform | Get Alert |
| 05/05/2023 | NUVB | Buy Now | Nuvation Bio | $1.91 | 161.51% | Gregory Renza49% | $6 → $5 | Maintains | Outperform | Get Alert |
| 05/04/2023 | PCRX | Buy Now | Pacira BioSciences | $23.67 | 204.18% | Gregory Renza49% | $75 → $72 | Maintains | Outperform | Get Alert |
| 04/26/2023 | MORF | Buy Now | Morphic Holding | — | — | Gregory Renza49% | $75 → $80 | Maintains | Outperform | Get Alert |
| 04/19/2023 | BLU | Buy Now | BELLUS Health | — | — | Gregory Renza49% | $21 → $14.75 | Downgrade | Outperform → Sector Perform | Get Alert |
| 04/18/2023 | RXDX | Buy Now | Prometheus Biosciences | — | — | Gregory Renza49% | $140 → $200 | Downgrade | Outperform → Sector Perform | Get Alert |
| 04/14/2023 | NRIX | Buy Now | Nurix Therapeutics | $13.66 | 119.62% | Gregory Renza49% | → $30 | Reiterates | → Outperform | Get Alert |
| 03/24/2023 | APTO | Buy Now | Aptose Biosciences | $3.78 | 32.28% | Gregory Renza49% | → $2250 | Reiterates | → Outperform | Get Alert |
| 03/22/2023 | BLU | Buy Now | BELLUS Health | — | — | Gregory Renza49% | → $21 | Reiterates | → Outperform | Get Alert |
| 03/20/2023 | SPRB | Buy Now | Spruce Biosciences | $0.34 | 2241.24% | Gregory Renza49% | → $8 | Reiterates | → Outperform | Get Alert |
| 03/16/2023 | NUVB | Buy Now | Nuvation Bio | $1.91 | 213.81% | Gregory Renza49% | → $6 | Reiterates | → Outperform | Get Alert |
| 03/15/2023 | VSTM | Buy Now | Verastem | $6.50 | -53.85% | Gregory Renza49% | → $36 | Reiterates | → Outperform | Get Alert |
| 03/14/2023 | VIRX | Buy Now | Viracta Therapeutics | $0.02 | 32553.06% | Gregory Renza49% | → $8 | Reiterates | → Outperform | Get Alert |
| 03/14/2023 | SGEN | Buy Now | Seagen | — | — | Gregory Renza49% | $155 → $229 | Maintains | Outperform | Get Alert |
| 03/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 50% | Gregory Renza49% | → $27 | Reiterates | → Outperform | Get Alert |
| 03/10/2023 | LIFE | Buy Now | aTyr Pharma | — | — | Gregory Renza49% | → $19 | Reiterates | → Outperform | Get Alert |
| 03/08/2023 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 35.35% | Gregory Renza49% | → $25 | Reiterates | → Outperform | Get Alert |
| 03/07/2023 | VRCA | Buy Now | Verrica Pharmaceuticals | $0.65 | 1592.31% | Gregory Renza49% | → $11 | Reiterates | → Outperform | Get Alert |
| 03/02/2023 | LIFE | Buy Now | aTyr Pharma | — | — | Gregory Renza49% | $20 → $19 | Maintains | Outperform | Get Alert |
| 03/02/2023 | INO | Buy Now | Inovio Pharmaceuticals | $2.12 | -5.66% | Gregory Renza49% | $36 → $24 | Maintains | Sector Perform | Get Alert |
| 03/01/2023 | PCRX | Buy Now | Pacira BioSciences | $23.67 | 221.08% | Gregory Renza49% | $80 → $76 | Maintains | Outperform | Get Alert |
| 02/28/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 50% | Gregory Renza49% | $19 → $27 | Maintains | Outperform | Get Alert |
| 02/28/2023 | IDYA | Buy Now | IDEAYA Biosciences | $18.47 | 35.35% | Gregory Renza49% | → $25 | Initiates | → Outperform | Get Alert |
| 02/16/2023 | SGEN | Buy Now | Seagen | — | — | Gregory Renza49% | $145 → $155 | Maintains | Outperform | Get Alert |
| 02/13/2023 | SPRB | Buy Now | Spruce Biosciences | $0.34 | 2241.24% | Gregory Renza49% | $9 → $8 | Maintains | Outperform | Get Alert |
| 02/13/2023 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 555.74% | Gregory Renza49% | $18 → $12 | Maintains | Outperform | Get Alert |
| 02/13/2023 | VRCA | Buy Now | Verrica Pharmaceuticals | $0.65 | 1592.31% | Gregory Renza49% | $4 → $11 | Upgrade | Sector Perform → Outperform | Get Alert |
| 02/10/2023 | NRIX | Buy Now | Nurix Therapeutics | $13.66 | 119.62% | Gregory Renza49% | $39 → $30 | Maintains | Outperform | Get Alert |
| 02/01/2023 | AMGN | Buy Now | Amgen | $319.93 | -19.36% | Gregory Renza49% | $268 → $258 | Maintains | Sector Perform | Get Alert |
| 12/08/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Gregory Renza49% | $66 → $111 | Maintains | Outperform | Get Alert |
| 11/11/2022 | VIRX | Buy Now | Viracta Therapeutics | $0.02 | 32553.06% | Gregory Renza49% | $10 → $8 | Maintains | Outperform | Get Alert |
| 11/10/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $139.51 | 48.38% | Gregory Renza49% | $206 → $207 | Maintains | Outperform | Get Alert |
| 11/09/2022 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 992.9% | Gregory Renza49% | $25 → $20 | Maintains | Outperform | Get Alert |
| 11/08/2022 | XNCR | Buy Now | Xencor | $12.52 | 187.54% | Gregory Renza49% | $40 → $36 | Maintains | Outperform | Get Alert |
| 11/04/2022 | AMGN | Buy Now | Amgen | $319.93 | -24.98% | Gregory Renza49% | $235 → $240 | Maintains | Sector Perform | Get Alert |
| 11/03/2022 | MORF | Buy Now | Morphic Holding | — | — | Gregory Renza49% | $70 → $75 | Maintains | Outperform | Get Alert |
| 11/03/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 16.67% | Gregory Renza49% | $22 → $21 | Maintains | Outperform | Get Alert |
| 11/02/2022 | EXEL | Buy Now | Exelixis | $36.36 | -20.24% | Gregory Renza49% | $31 → $29 | Maintains | Outperform | Get Alert |
| 11/02/2022 | APTO | Buy Now | Aptose Biosciences | $3.78 | 32.28% | Gregory Renza49% | $2700 → $2250 | Maintains | Outperform | Get Alert |
| 10/28/2022 | SGEN | Buy Now | Seagen | — | — | Gregory Renza49% | $185 → $178 | Maintains | Outperform | Get Alert |
| 10/04/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Gregory Renza49% | $61 → $66 | Maintains | Outperform | Get Alert |
| 09/30/2022 | BLU | Buy Now | BELLUS Health | — | — | Gregory Renza49% | $19 → $21 | Maintains | Outperform | Get Alert |
| 08/16/2022 | SGEN | Buy Now | Seagen | — | — | Gregory Renza49% | $179 → $188 | Upgrade | Sector Perform → Outperform | Get Alert |
| 08/10/2022 | INO | Buy Now | Inovio Pharmaceuticals | $2.12 | 41.52% | Gregory Renza49% | $48 → $36 | Maintains | Sector Perform | Get Alert |
| 08/10/2022 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 1484.7% | Gregory Renza49% | $30 → $29 | Maintains | Outperform | Get Alert |
| 08/09/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 16.67% | Gregory Renza49% | $26 → $21 | Maintains | Outperform | Get Alert |
| 08/09/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | Gregory Renza49% | $60 → $68.5 | Downgrade | Outperform → Sector Perform | Get Alert |
| 08/04/2022 | MORF | Buy Now | Morphic Holding | — | — | Gregory Renza49% | $76 → $70 | Maintains | Outperform | Get Alert |
| 07/13/2022 | BLU | Buy Now | BELLUS Health | — | — | Gregory Renza49% | $14 → $19 | Maintains | Outperform | Get Alert |
| 06/21/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 44.44% | Gregory Renza49% | $32 → $26 | Maintains | Outperform | Get Alert |
| 05/13/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Gregory Renza49% | $46 → $45 | Maintains | Outperform | Get Alert |
| 05/11/2022 | NUVB | Buy Now | Nuvation Bio | $1.91 | 632.22% | Gregory Renza49% | $15 → $14 | Maintains | Outperform | Get Alert |
| 05/10/2022 | LIFE | Buy Now | aTyr Pharma | — | — | Gregory Renza49% | $22 → $20 | Maintains | Outperform | Get Alert |
| 05/10/2022 | APTO | Buy Now | Aptose Biosciences | $3.78 | 58.73% | Gregory Renza49% | $3150 → $2700 | Maintains | Outperform | Get Alert |
| 05/10/2022 | ADCT | Buy Now | ADC Therapeutics | $1.83 | 1539.34% | Gregory Renza49% | $34 → $30 | Maintains | Outperform | Get Alert |
| 05/05/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $139.51 | 49.09% | Gregory Renza49% | $210 → $208 | Maintains | Outperform | Get Alert |
| 04/29/2022 | SGEN | Buy Now | Seagen | — | — | Gregory Renza49% | $132 → $136 | Maintains | Sector Perform | Get Alert |
| 04/28/2022 | AMGN | Buy Now | Amgen | $319.93 | -30.3% | Gregory Renza49% | $218 → $223 | Maintains | Sector Perform | Get Alert |
| 04/18/2022 | NRIX | Buy Now | Nurix Therapeutics | $13.66 | 185.51% | Gregory Renza49% | $42 → $39 | Maintains | Outperform | Get Alert |
| 04/14/2022 | VSTM | Buy Now | Verastem | $6.50 | -23.08% | Gregory Renza49% | → $60 | Initiates | → Outperform | Get Alert |
| 03/16/2022 | APRE | Buy Now | Aprea Therapeutics | $2.40 | 66.67% | Gregory Renza49% | $100 → $80 | Maintains | Sector Perform | Get Alert |
| 03/15/2022 | SPRB | Buy Now | Spruce Biosciences | $0.34 | 2533.89% | Gregory Renza49% | $13 → $9 | Maintains | Outperform | Get Alert |
| 03/03/2022 | AVTX | Buy Now | Avalo Therapeutics | $7.38 | -45.8% | Gregory Renza49% | $14400 → $11520 | Maintains | Outperform | Get Alert |
| 03/02/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $139.51 | 53.39% | Gregory Renza49% | $216 → $214 | Maintains | Outperform | Get Alert |
| 03/02/2022 | INO | Buy Now | Inovio Pharmaceuticals | $2.12 | 135.86% | Gregory Renza49% | $72 → $60 | Maintains | Sector Perform | Get Alert |
| 02/25/2022 | MORF | Buy Now | Morphic Holding | — | — | Gregory Renza49% | $82 → $76 | Maintains | Outperform | Get Alert |
| 12/21/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 88.89% | Gregory Renza49% | $32 → $34 | Maintains | Outperform | Get Alert |
| 12/13/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | Gregory Renza49% | → $46 | Initiates | → Outperform | Get Alert |
| 12/07/2021 | BLU | Buy Now | BELLUS Health | — | — | Gregory Renza49% | $9 → $11 | Maintains | Outperform | Get Alert |
| 11/05/2021 | GBT | Buy Now | Global Blood Therapeutics | — | — | Gregory Renza49% | $66 → $64 | Maintains | Outperform | Get Alert |
| 11/01/2021 | INO | Buy Now | Inovio Pharmaceuticals | $2.12 | 183.03% | Gregory Renza49% | $84 → $72 | Maintains | Sector Perform | Get Alert |
| 10/18/2021 | BLU | Buy Now | BELLUS Health | — | — | Gregory Renza49% | $8 → $9 | Maintains | Outperform | Get Alert |
| 09/24/2021 | AVTX | Buy Now | Avalo Therapeutics | $7.38 | -18.7% | Gregory Renza49% | → $17280 | Initiates | → Outperform | Get Alert |
| 09/21/2021 | VRCA | Buy Now | Verrica Pharmaceuticals | $0.65 | 2361.54% | Gregory Renza49% | $19 → $16 | Maintains | Outperform | Get Alert |
| 08/13/2021 | APRE | Buy Now | Aprea Therapeutics | $2.40 | 108.33% | Gregory Renza49% | $120 → $100 | Maintains | Sector Perform | Get Alert |
| 04/09/2021 | PRVB | Buy Now | Provention Bio | — | — | Gregory Renza49% | $25 → $10 | Downgrade | Outperform → Sector Perform | Get Alert |
| 03/17/2021 | APRE | Buy Now | Aprea Therapeutics | $2.40 | 233.33% | Gregory Renza49% | $200 → $160 | Maintains | Sector Perform | Get Alert |
| 02/02/2021 | MORF | Buy Now | Morphic Holding | — | — | Gregory Renza49% | $35 → $50 | Maintains | Outperform | Get Alert |
| 01/29/2021 | BLU | Buy Now | BELLUS Health | — | — | Gregory Renza49% | → $8 | Initiates | → Outperform | Get Alert |
| 12/29/2020 | APRE | Buy Now | Aprea Therapeutics | $2.40 | 316.67% | Gregory Renza49% | $800 → $200 | Downgrade | Outperform → Sector Perform | Get Alert |
| 12/03/2020 | GBT | Buy Now | Global Blood Therapeutics | — | — | Gregory Renza49% | → $75 | Initiates | → Outperform | Get Alert |
| 11/03/2020 | SPRB | Buy Now | Spruce Biosciences | $0.34 | 8094.32% | Gregory Renza49% | → $28 | Initiates | → Outperform | Get Alert |
| 07/21/2020 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 205.56% | Gregory Renza49% | $61 → $55 | Maintains | Outperform | Get Alert |
| 06/04/2020 | PRVB | Buy Now | Provention Bio | — | — | Gregory Renza49% | → $25 | Initiates | → Outperform | Get Alert |
| 06/02/2020 | ITRM | Buy Now | Iterum Therapeutics | $1.42 | 40.85% | Gregory Renza49% | $105 → $30 | Downgrade | Outperform → Sector Perform | Get Alert |
| 04/23/2020 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Gregory Renza49% | → $20 | Initiates | → Outperform | Get Alert |
| 01/30/2020 | XNCR | Buy Now | Xencor | $12.52 | 251.44% | Gregory Renza49% | → $44 | Initiates | → Outperform | Get Alert |
| 12/11/2019 | ITRM | Buy Now | Iterum Therapeutics | $1.42 | 604.23% | Gregory Renza49% | $210 → $150 | Maintains | Outperform | Get Alert |
| 12/10/2019 | ARQL | Buy Now | Arqule | — | — | Gregory Renza49% | $12 → $20 | Downgrade | Outperform → Sector Perform | Get Alert |
| 10/28/2019 | APRE | Buy Now | Aprea Therapeutics | $2.40 | 1275% | Gregory Renza49% | → $660 | Initiates | → Outperform | Get Alert |
| 10/01/2019 | ACAD | Buy Now | ACADIA Pharmaceuticals | $18.00 | 233.33% | Gregory Renza49% | → $60 | Initiates | → Outperform | Get Alert |
| 04/11/2019 | ARQL | Buy Now | Arqule | — | — | Gregory Renza49% | → $9 | Initiates | → Outperform | Get Alert |
| 11/20/2018 | GMDA | Buy Now | Gamida Cell | — | — | Gregory Renza49% | → $20 | Initiates | → Outperform | Get Alert |
| 06/19/2018 | ITRM | Buy Now | Iterum Therapeutics | $1.42 | 1590.14% | Gregory Renza49% | → $360 | Initiates | → Outperform | Get Alert |
| 12/21/2015 | ARQL | Buy Now | Arqule | — | — | Gregory Renza49% | — | Upgrade | Sector Perform → Outperform | Get Alert |
| 10/03/2012 | ARQL | Buy Now | Arqule | — | — | Gregory Renza49% | — | Downgrade | Outperform → Sector Perform | Get Alert |
